Skip to main content
Sign In
 

Research


Principle Investigator

Sponsor

Type

Title

Dreskin, Stephen

NIH

R01 

Redefining the Major Peanut Allergens. 

Fontenot, Andrew

NIH/NHLBI

R01

Pathogenic T Cells in Chronic Beryllium Disease.

 

NIH/NIEHS

P01

T Cells in Beryllium Sensitization and Disease.

 

NIH/NHLBI

U01

Alterations in the Lung Microbiome in Acute and Chronic HIV-1 Disease.

 

NIH/NHLBI

K24

Patient-Oriented Research in Beryllium-Induced Disease.

Freed, Brian

HRSA 

1-3 yr 

National Cord Blood Inventory. 

Philip Morris 3 yr Inhibition of T Cell Activation by Thiol-Reactive Aldehydes.

Kirkpatrick, Charles

Pharming

Clinical Trial

R, PC, DB, Phase II Study of the Safety and Efficacy of Recombinant Human CI Inhibitor for the Treatment of Acute Attacks in Patients with Hereditary Angioedema.

 

Hesperion (Jerini)

Clinical Trial

R, DB, PC, Multicenter Study of a Subcutaneous Formulation of Icatibant for the Treatment of Hereditary Angioedema.

 

 

 

 

 

 

 

 

Newman, Lee

NIEHS

P01

Beryllium: Exposure, Immune and Genetic Mechanisms.

 

DOE (sub through NJH)

Coop Agree.

Repository for Chronic Beryllium Disease.

 

CDC/NIOSH

T32

Mountain and Plains Education and Research Center.

 

DOE (sub through Oak Ridge Assoc. Univer.

Coop Agree.

National Supplemental Screening Program.

 

US/Israel Binational Science Foundation

Grant

CBD Worldwide Unrecognized Epedemic: Surveillance, Monitoring and Diagnosis Novel Program.

 

Garfield County Board of County Commissioners

Grant

Battlement Mesa Health Impact Assessment and Health Monitoring Study.

Palmer, Brent

NIAID/NIH

R21

Enhancement of HIV-Specific CD4+ T Cell Function By Blockade of the PD-1 Pathway.

 

VaxInnate

2 yr

Evaluation of Conserved Influenza Immunogenicity.

Simonian, Philip

NHLBI

5 yr

Gamma Delta T Cells and Pulmonary Fibrosis